22 July 2016

Result of GM

PR Newswire

Read more

1 July 2016

Notice of GM

PR Newswire

Read more

27 June 2016

Result of AGM

PR Newswire

Read more

20 June 2016

Proposed Placing and Notice of General Meeting

PR Newswire

Read more

17 June 2016

Proposed Placing and Notice of General Meeting

PR Newswire

Read more

3 June 2016

Final Results

VERONA PHARMA PLC - Final Results

Read more

3 June 2016

2015 Annual Report and Accounts, Notice of AGM

PR Newswire

Read more

27 May 2016

Notice of Results

VERONA PHARMA PLC - Notice of Results

Read more

10 May 2016

Verona Pharma announces positive results from “add-on” Phase II trial with RPL554

Read more

4 May 2016

Verona to present RPL554 at the ATS Conference

VERONA PHARMA PLC - Verona to present RPL554 at the ATS Conference

Read more

Targeting unmet needs

384m people worldwide suffer from COPD and 37 years is the median life expectancy of CF patients

Read more about COPD and CF in the unmet needs section of this website

Go

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us